Company Overview of Excelimmune, Inc.
Excelimmune, Inc., a biopharmaceutical company, engages in the development of human recombinant polyclonal antibodies for therapeutic use. The company focuses on the treatment of infections caused by staphylococcus aureus, including the drug resistant superbug, methicillin-resistant staphylococcus aureus. It offers a platform for developing human recombinant polyclonal antibody therapeutics for therapeutic applications, such as the treatment of infectious diseases, protein diseases, and cancer. Excelimmune, Inc. was founded in 2006 and is based in Woburn, Massachusetts.
12-B Cabot Road
Woburn, MA 01801
Founded in 2006
Key Executives for Excelimmune, Inc.
Excelimmune, Inc. Key Developments
Similar Private Companies By Industry
|Glycoregimmune, Inc.||United States|
|Center for Biocatalysis and Bioprocessing||United States|
|Applied Catheter Technologies, Inc.||United States|
|Tolerance Therapeutics LLC||United States|
|Genevac, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Excelimmune, Inc., please visit www.excelimmune.com. Company data is provided by Capital IQ. Please use this form to report any data issues.